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and agr genes in Staphylococcus aureus strains isolated from psoriasis patients*
1,

2

2

3

Jülide Sedef GÖÇMEN **, Neriman ŞAHİNER , Mukadder KOÇAK , Zeynep Ceren KARAHAN
1
Department of Medical Microbiology, Faculty of Medicine, Başkent University, Ankara, Turkey
2
Department of Dermatology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey
3
Department of Medical Microbiology, Faculty of Medicine, Ankara University, Ankara, Turkey
Received: 13.08.2014

Accepted/Published Online: 28.12.2014

Printed: 31.12.2015

Background/aim: Staphylococcus aureus colonization is a determiner of disease activation in psoriasis patients. Here we evaluate
the presence of genes encoding Panton-Valentine leukocidin (PVL), enterotoxins, TSST-1, exfoliative toxins, and the accessory gene
regulatory locus by polymerase chain reaction (PCR) in S. aureus isolates obtained from healthy and diseased skin regions and anterior
nares of psoriasis patients and healthy controls.
Materials and methods: The presence of PVL and toxin genes was investigated, and agr typing was performed by PCR.
Results: Eighteen of the isolated strains carried the sei, 1 carried the seb-sec, and 1 carried the seg enterotoxin gene. Eight of the strains
carrying enterotoxin genes were isolated from nasal swabs, 6 from diseased skin swabs, and 4 from healthy skin swabs. None of the
strains isolated from the control group carried the agr locus. On the other hand, 11 of the S. aureus strains isolated from the patients
carried type 1, 7 carried type 1 + 3, 4 carried type 2, 4 carried type 3, and 1 carried type 1 + 2 agr loci.
Conclusion: Enterotoxin production and the carried accessory gene regulatory locus may be important in the aggravation of psoriasis.
Key words: Polymerase chain reaction, Staphylococcus aureus, toxin genes, agr typing

1. Introduction
Psoriasis is a chronic inflammatory disorder involving the
skin. Genetic, environmental, and immunological factors
play important roles in the development of the disease.
Its incidence may change in different parts of the world
depending on environmental, ethnic, and geographic
differences. Both sexes are affected equally by the disease,
and patients are usually diagnosed between 15 and 30
years of age. Although it can be seen in almost all races,
it is rare in Asia and Africa. It has an overall prevalence of
2%–3% in the general population (1,2). Its prevalence in
children is reported to range from 0% (Taiwan) to 2.1%
(Italy), and in adults from 0.91% (United States) to 8.5%
(Norway). In the United States, the annual incidence
estimate in children is 40.8/100,000, while in adults the
annual incidence varies from 78.9/100,000 (United States)
to 230/100,000 (Italy) (1). The prevalence in the Turkish
population is reported as 1.3% (2).

Bacteria are known to play an important role in the
development and chronicity of chronic inflammatory
diseases such as atopic dermatitis and psoriasis. The
relationship between bacterial colonization or infection
of the skin and the development of inflammatory skin
diseases is well described in studies reporting the relapse
of guttate psoriasis following streptococcal pharyngitis
and the development of atopic dermatitis following
Staphylococcus aureus colonization of the skin (3,4).
S. aureus colonizes the anterior nares of 20%–40%
of the healthy adult population. It can also colonize the
perineum, perianal region, axilla, gastrointestinal tract,
and skin folds. Trauma, burns, diabetes, and immune
suppression can lead to opportunistic infections with this
colonizing pathogen (5).
S. aureus can be the cause of a wide spectrum of
infectious diseases due to its many virulence factors,
which facilitate its spread in host tissues and its escape
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from the host’s immune responses. Bacterial enzymes and
toxins, such as capsular polysaccharide, plasma coagulase,
extracellular matrix components, protein A, fibronectin
binding factor, microbial surface component recognizing
adhesive matrix molecules, and extracellular proteins
(i.e. toxins), play important roles in the development and
occurrence of staphylococcal infections (6,7) . Adherence
factors (adhesins) promote the colonization of S. aureus on
host cell surfaces (8–11).
S. aureus produces exotoxins with cytolytic activities.
These cytolytic toxins (α-, β-, and γ-hemolysins,
leukocidin, and Panton-Valentine leukocidin [PVL]) lead
to the formation of pores on target cell membranes. The
cytoplasmic content of the target cell leaks and the cell lyses.
PVL is a bicomponent cytolysin (LukF-PV and LukS-PV)
and is cytotoxic for erythrocytes and leukocytes, just like
γ-hemolysin and leukocidin, which show high affinity for
leukocytes. α-Hemolysin is especially responsible for osmotic
cytolysis of human thrombocytes and monocytes (12–16).
S. aureus secretes toxic shock syndrome toxin-1
(TSST-1), staphylococcal enterotoxins A-I (SEA, SEB,
SECN, SED, SEE, SEG, SEH and SEI), and exfoliative
toxins A and B (ETA and ETB). Among these, TSST-1
and staphylococcal enterotoxins belong to the group of
pyrogenic toxin superantigens (17,18).
Superantigens (SAgs) are toxins that play a role in T-cell
proliferation. These toxins cause TSST-1, food poisoning
(enterotoxins), and staphylococcal scalded skin syndrome
(ETA and ETB) (19). The issue of whether exfoliative
toxins have any mitogenic activity on T lymphocytes as
SAgs is still controversial (20).
S. aureus has some special proteins that may have an
effect on innate and acquired immunity. Staphylococcal
complement inhibitor, chemotaxis-inhibitory protein of
S. aureus, staphylokinase, extracellular fibrinogen-binding
protein, extracellular adherence protein, and formyl
peptide receptor like-1 inhibitory protein are some of
these special proteins (21–27).
In this study, in order to contribute to the previous
studies on whether or not S. aureus colonization is a
determiner of disease activation in psoriasis patients, we
evaluated the presence of genes encoding PVL, enterotoxins
(sea, seb, sec, sed, see, seg, seh, sei, sej), TSST-1 (tst),
exfoliative toxins (eta, etb), and accessory gene regulatory
locus (agr) by polymerase chain reaction (PCR) in S. aureus
isolates obtained from healthy and diseased skin regions
and anterior nares of psoriasis patients and healthy controls.

University School of Medicine. The control group consisted
of 48 healthy volunteers with no personal or family history
of psoriasis or other inflammatory skin disorders. Nasal
and cubital volar skin swabs were obtained from the
control group. Ethics committee approval was received
for this study from the Ethics Committee of the Kırıkkale
University Medical Faculty (Approval Number: 2010/004),
and informed consent was obtained from all study and
control subjects.
2.2. Culture
All swabs were cultured on 5% sheep blood agar in the
Medical Microbiology Department Laboratory of the
Kırıkkale University School of Medicine. Staphylococcus
identification was made by conventional microbiological
methods (Gram staining, catalase, and coagulase tests).
Methicillin resistance of the isolates was determined by a
Kirby-Bauer disk diffusion test performed by using 1 µg
oxacillin and 30 µg cefoxitin disks (Bioanalyse, Turkey)
according to the Clinical and Laboratory Standards
Institute instructions (28). Methicillin-resistant S. aureus
(MRSA) ATCC 43300 and methicillin-sensitive S. aureus
(MSSA) ATCC 25923 control strains were used as standard
quality controls for susceptibility testing in the Medical
Microbiology Department Laboratory of the Başkent
University School of Medicine. All the strains were stored
in brain-heart infusion broth containing 20% glycerol at
–80 °C until molecular testing was performed.
2.3. Molecular analyses
Molecular analyses of the strains were performed in
the Molecular Microbiology Diagnostics and Research
Laboratory of the Ankara University School of Medicine,
Department of Medical Microbiology. All the strains
were subcultured on nutrient agar plates, and DNA was
extracted by boiling. Briefly, 2 loopfuls of pure culture
were suspended in 500 µL of sterile distilled water and
boiled at 95 °C for 10 min. The suspension was centrifuged
at 3500 × g for 5 min, and the supernatant was used for
PCR analysis. The presence of PVL, enterotoxin and TSST1 (sea, seb, sec, sed, see, seg, seh, sei, sej, tst), and exfoliative
toxin (eta, etb) genes was investigated, and agr typing
was performed by PCR as described in the literature
(12,13,29,30). The primer sets used for molecular analysis
are given in Table 1.
2.4. Statistical analysis
Cochran Q and two-proportion z-tests were performed
for the statistical analysis of the results using the SPSS 17.0
(SPSS Inc., Chicago IL, USA). P < 0.05 was considered as
statistically significant.

2. Materials and methods
2.1. Patients
Diseased skin, healthy skin (cubital volar region), and
nasal swabs were obtained from 61 psoriasis patients
who attended the dermatology polyclinic of the Kırıkkale

3. Results
3.1. Culture results
Of the 61 psoriasis patients, 26 (42.6%) were found to
carry S. aureus on their diseased and/or healthy skin
and/or anterior nares. A total of 56 S. aureus strains were
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Table 1. The primers used for molecular analysis of S. aureus strains.
Gene
sea

seb-sec

sec

sed

see

seg

seh

sei

sej

tst

16S rRNA

eta

etb

PVL

Primer (5′-3′)
GCAGGGAACAGCTTTAGGC
GTTCTGTAGAAGTATGAAACACG
ATGTAATTTTGATATTCGCAGTG
TGCAGGCATCATATCATACCA
CTTGTATGTATGGAGGAATAACAA
TGC AGG CAT CAT ATC ATA CCA
GTGGTGAAATAGATAGGACTGC
ATATGAAGGTGCTCTGTGG
TACCAATTAACTTGTGGATAGAC
CTCTTTGCACCTTACCGC
CGTCTCCACCTGTTGAAGG
CCAAGTGATTGTCTATTGTCG
CAACTGCTGATTTAGCTCAG
GTCGAATGAGTAATCTCTAGG
CAACTCGAATTTTCAACAGGTAC
CAGGCAGTCCATCTCCTG
CATCAGAACTGTTGTTCCGCTAG
CTGAATTTTACCATCAAAGGTAC
GCTTGCGACAACTGCTACAG
TGGATCCGTCATTCATTGTTAA
GTAGGTGGCAAGCGTTATCC
CGC ACA TCA GC GTC AG
GCAGGTGTTGATTTAGCATT
AGATGTCCCTATTTTTGCTG
ACAAGCAAAAGAATACAGCG
GTTTTTGGCTGCTTCTCTTG
ATCATTAGGTAAAATGTCTGGACATGATCCA
GCA TCA AGT GTA TTG GAT AGC AAA AGC

Product size (bp)

Reference

520

643

283

384

170

327

(30)

360

465

142

559

228

93
(30)
226

433

agr1

GTCACAAGTACTATAAGCTGCGAT

441

agr2

TATTACTAATTGAAAAGTGGCCATAGC

575

agr3

GTAATGTAATAGCTTGTATAATAATACCCAG

323

agr4

CGATAATGCCGTAATACCCG

659

agr-PanR

ATGCACATGGTGCACATGC

(12,13)

(29)
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isolated from swab cultures of these 26 patients. Twentyfour (43%) of the strains were isolated from nasal cultures,
20 (36%) from diseased skin swabs, and 12 (21%) from
healthy skin swabs.
In the control group, only 4 (8.3%) nasal swabs were
positive for S. aureus colonization. All of the isolated S.
aureus strains were methicillin-susceptible.
Nasal S. aureus carriage rate was statistically
significantly higher in the patient group when compared
to the control group (36% versus 8.3%, P < 0.001). None
of the healthy skin cultures yielded S. aureus growth in
the control group. S. aureus carriage rates on diseased
and healthy skin of psoriasis patients were statistically
significantly higher than in the control group (21% versus
0%, P < 0.001, and 36% versus 0%, P < 0.001).
In the patient group, culture positivity of diseased skin
correlated with nasal culture positivity (16 patients carried
S. aureus both in the nares and on diseased skin, P = 0.453).
Healthy skin cultures yielded less S. aureus positivity when
compared to nasal (P < 0.001) and diseased skin (P =
0.001953) cultures.

3.2. Results of molecular analyses
None of the S. aureus strains isolated from the study and
control groups carried PVL or exfoliative toxin genes.
None of the strains isolated from the control group carried
toxin genes. In the patient group, 18 (32.1%) of the isolated
strains carried the sei, 1 (1.8%) carried the seb-sec, and 1
(1.8%) carried the seg enterotoxin gene (Figure 1).
Eight of the strains carrying enterotoxin genes were
isolated from nasal swabs, 6 from diseased skin swabs, and
4 from healthy skin swabs.
The differences of toxin genes among isolation sites
were statistically insignificant (P = 0.135).
None of the strains isolated from the control group
carried the agr locus. On the other hand, 11 (19.7%) of the
S. aureus strains isolated from the patients carried type 1, 7
(12.5%) carried type 1 + 3, 4 (7.1%) carried type 2, 4 (7.1%)
carried type 3, and 1 (1.8%) carried type 1 + 2 agr loci (Figure
2). Twelve of these strains were isolated from nasal swabs,
10 from diseased skin swabs, and 5 from healthy skin swabs.
The agr locus was carried at a significantly higher rate in S.

Figure 1. Enterotoxin genes identified by PCR. M represents 50-bp molecular weight marker (Fermentas, Lithuania), IC represents
internal control (228-bp product of S. aureus 16S rRNA gene).

Figure 2. agr typing of the strains. M represents 50-bp molecular weight marker (Fermentas, Lithuania).
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aureus strains isolated from nasal swabs and diseased skin
swabs than the strains isolated from healthy skin swabs (P

< 0.05). The distributions of toxin genes and agr types are
given in Table 2 and Figures 3 and 4.

Table 2. Distribution of S. aureus strains isolated from patients according to their sampling sites, identified enterotoxin genes, and agr types.
Patient no.
1
2
3
4
5
6

7

8

9

10

11
12

13
14
15
16

17

18
19
20

21
22
23
24

25
26

Sampling site
Nasal
Nasal
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Nasal
Nasal
Diseased skin
Nasal
Diseased skin
Healthy skin
Nasal
Diseased skin
Healthy skin
Nasal
Healthy skin
Nasal
Diseased skin
Nasal
Diseased skin
Healthy skin
Nasal
Nasal
Diseased skin
Nasal
Diseased skin
Nasal
Diseased skin
Healthy skin
Diseased skin
Nasal
Diseased skin

Genes identified
agr types
1

2

3

Enterotoxin genes
sei
seb-sec
+
+

seg

+
+
+
+
+

+
+
+

+
+
+
+
+
+
+
+
+

+
+
+
+

+

+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+

+
+
+
+
+
+
+

+
+

+
+

+
+

1349

GÖÇMEN et al. / Turk J Med Sci
30
25

Agr

20

Negative

Toxin

16
14
12
10
8
6
4
2
0

15
10
5
0

Nasal
(n=24)

Diseased skin
(n=20)

Healty skin
(n=12)

Total (n=56)

Nasal (n=24)
Diseased skin (n=20)
Healthy skin (n=12)
Total (n=56)

1

2

3
Agr

1+2

1+3

sei

seb-sec

seq

Toxin

Figure 3. Toxin and agr locus presence among the strains isolated
from psoriasis patients according to their sampling sites.

Figure 4. Enterotoxin and agr type distribution among S. aureus
strains according to their sampling sites.

4. Discussion
Psoriasis is a chronic inflammatory disease affecting many
components of the immune system. It is characterized
by epidermal hyperproliferation and inflammation. Its
pathogenesis involves complicated relationships among
many cell types, cytokines, chemokines, and skin-derived
chemical mediators. The interaction between these
components leads to dysregulation in the immune system
(31).
Bacterial products and SAgs such as staphylococcal
enterotoxins, TSST-1, exfoliative toxins, streptococcal
pyrogenic exotoxins, mycoplasma arthritis supernatant,
chemicals, UV light, and trauma may take part in the
development or aggravation of inflammatory skin diseases
(3,4). Toxins and enzymes secreted by the bacteria have an
important role in staphylococcal infections. Among these,
enterotoxins are encoded by sea-sej genes, TSST-1 by the
tst gene, and exfoliative toxins A and B by the eta and etb
genes (32–34).
Another important virulence factor of S. aureus is PVL.
It is responsible for pore formation on the membranes of
polymorphonuclear leukocytes, leading to cell lysis (12).
PVL-secreting strains are responsible for severe skin and
soft tissue infections and necrotizing pneumonia (35).
None of our patients were colonized with PVL-positive
or MRSA strains, both of which may be considered as a
benefit for our patients.
Expression of virulence proteins in S. aureus is under
the control of RNA III, which is a small RNA molecule
regulating the expression of S. aureus genes for exoproteins
and cell membrane proteins. It is the intracellular effector
of the quorum sensing system. Secreted proteases are
under the control of the agr gene (36). In our study, 26
(46.42%) of the 56 S. aureus strains carried the agr locus,
suggesting that secreted proteases may play a role in the
aggravation of psoriasis.

The relationship between bacterial SAgs and skin
diseases is shown in guttate psoriasis, atopic dermatitis,
and cutaneous lupus erythematosus. The mechanism of
how SAgs lead to inflammation is not known extensively.
SAg-mediated T-cell activation may be involved (35).
In the study of Balcı et al. (37), 64% of the diseased
and 14% of healthy skin cultures obtained from psoriasis
patients were found to be positive for S. aureus. They also
found a significant relationship between toxin production
of the strains isolated from skin lesions and disease grades
(37). These results support the findings of previous studies
(38,39). Tomi et al. (39) showed that 36% of the S. aureus
strains isolated from skin lesions of psoriasis patients
secreted toxins. In the same study, psoriasis patients who
carried toxin-negative and toxin-positive S. aureus strains
were compared, and disease grades of the patients with
toxin-positive strains were found to be higher. These
results show that there is a relationship between toxinpositive S. aureus colonization and psoriasis activation
(39). On the other hand, Sayama et al. (40) could only
demonstrate the presence of enterotoxin (seb) and tst-1 in
5 of the 100 S. aureus strains isolated from diseased skin
swabs of psoriasis patients, and they concluded that SAgs
do not have a role in the development of psoriasis (40).
In our study, we observed that patients who carry S.
aureus on psoriasis lesions are more likely to also carry
S. aureus nasally. Healthy skin culture positivity was
significantly less prevalent in the patient group. If nasal
carriage is regarded as the primary focus, psoriasis lesions
can be considered as more prone to the development of
S. aureus colonization when compared to healthy skin.
Another question requiring explanation is the mechanism
underlying the high frequency of nasal S. aureus carriage
among psoriasis patients.
The results of our study demonstrated the presence
of toxin genes in 20 (35.71%) of the 56 MSSA strains.
Among diseased skin isolates (n = 7), 6 carried the sei and
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1 the seg gene. Four of the 11 healthy skin isolates carried
the sei gene, and of the 9 nasal isolates, 8 carried the sei
gene and 1 the seb-sec genes. There was no difference in
toxin production of isolates according to their sampling
sites. On the other hand, the 4 MSSA isolates obtained
from the control group did not carry toxin genes or the
agr locus. These findings suggest that enterotoxins may be
important in the aggravation of psoriasis as suggested in
previous studies (39,41). Although these previous studies
emphasized the high prevalence of enterotoxin genes
in S. aureus strains isolated from psoriasis patients and
correlated their presence with disease severity, they did
not investigate the prevalence of enterotoxin I, which was
the main enterotoxin gene found in our study. Whether

or not this finding has important correlations with disease
activation or severity needs further investigation.
Although there was no correlation between agr
positivity and isolation sites of S. aureus strains, this
study showed that S. aureus strains isolated from psoriasis
patients established a high prevalence for the presence of
the agr gene locus, which is responsible for the secretion
of proteases that facilitate the aggregation of the infecting
strain on to the skin. Thus, the high rate of agr positive
S. aureus colonization in psoriasis patients may be a
provocateur factor for disease activation attacks.
As a result, not only S. aureus colonization but also the
toxin positivity and agr gene presence may be important
for disease activation in psoriasis patients.
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